Auswirkungen der EU-Drogenstrategie (2013-2020) und des EU-Drogenaktionsplans (2017-2020) in Deutschland

This procedure asks about the effects of the EU's drug strategy (2013-2020) and action plan (2017-2020) within Germany. It seeks to understand how these EU policies have been implemented and what outcomes they have had on drug-related issues in the country. The inquiry focuses on the health sector and its response to drug use. It aims to gather information on the practical application of EU drug policies at the national level and their impact on public health initiatives.